KLAGSBRUN; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for KLAGSBRUN; Michael.The latest application filed is for "methods and compositions for immunomodulation".

Company Profile

2.18.17

KLAGSBRUN; Michael - Newton MA
KLAGSBRUN; Michael - Brookline MA US
Klagsbrun; Michael - Newton Centre MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For Immunomodulation App 20190388505 - BRISCOE; David M. ; et al.	2019-12-26
Methods and compositions for immunomodulation Grant 10,456,445 - Briscoe , et al. Oc	2019-10-29
Methods And Compositions For Immunomodulation App 20170100456 - BRISCOE; David M. ; et al.	2017-04-13
Antagonists Of Neuropilin Receptor Function And Use Thereof App 20150025224 - Klagsbrun; Michael ; et al.	2015-01-22
Pharmaceutical compositions comprising peptide antagonists of vascular endothelial growth factor Grant 8,889,620 - Klagsbrun , et al. November 18, 2	2014-11-18
Soluble Inhibitors Of Vascular Endothelial Growth Factor And Use Thereof App 20140178986 - Klagsbrun; Michael ; et al.	2014-06-26
Antagonists Of Neuropilin Receptor Function And Use Thereof App 20140056872 - Klagsbrun; Michael ; et al.	2014-02-27
Soluble inhibitors of vascular endothelial growth factor and use thereof Grant 8,529,905 - Klagsbrun , et al. September 10, 2	2013-09-10
Peptide Antagonists Of Vascular Endothelial Growth Factor And Methods Of Use Thereof App 20130230504 - KLAGSBRUN; Michael ; et al.	2013-09-05
Peptide antagonists of vascular endothelial growth factor and methods of use thereof Grant 8,153,585 - Klagsbrun , et al. April 10, 2	2012-04-10
Method To Prognose Response To Anti-egfr Therapeutics App 20110052570 - Klagsbrun; Michael ; et al.	2011-03-03
Antagonists Of Neuropilin Receptor Function And Use Thereof App 20110002919 - Klagsbrun; Michael ; et al.	2011-01-06
Soluble Inhibitors Of Vascular Endothelial Growth Factor And Use Thereof App 20100267140 - KLAGSBRUN; Michael ; et al.	2010-10-21
Peptide Antagonists Of Vascular Endothelial Growth Factor App 20100249025 - KLAGSBRUN; Michael ; et al.	2010-09-30
Soluble inhibitors of vascular endothelial growth factor and use thereof Grant 7,736,655 - Klagsbrun , et al. June 15, 2	2010-06-15
Antagonists of neuropilin receptor function and use thereof Grant 7,731,959 - Klagsbrun , et al. June 8, 2	2010-06-08
Soluble inhibitors of vascular endothelial growth factor and use thereof App 20080261867 - Klagsbrun; Michael ; et al.	2008-10-23
Peptide antagonists of vascular endothelial growth factor Grant 7,414,027 - Klagsbrun , et al. August 19, 2	2008-08-19
Antagonists of neuropilin receptor function and use thereof App 20080076906 - Klagsbrun; Michael ; et al.	2008-03-27
Antagonists of neuropilin receptor function and use thereof Grant 7,335,357 - Klagsbrun , et al. February 26, 2	2008-02-26
Soluble inhibitors of vascular endothelial growth factor and use thereof Grant 7,273,612 - Klagsbrun , et al. September 25, 2	2007-09-25
Antagonists of neuroplin receptor function and use thereof App 20060251650 - Klagsbrun; Michael ; et al.	2006-11-09
Peptide antagonists of vascular endothelial growth factor App 20060166878 - Klagsbrun; Michael ; et al.	2006-07-27
Peptide antagonists of vascular endothelial growth factor Grant 6,777,534 - Klagsbrun , et al. August 17, 2	2004-08-17
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer Grant 6,635,421 - Klagsbrun , et al. October 21, 2	2003-10-21
Soluble inhibitors of vascular endothelial growth factor and use thereof App 20030104532 - Klagsbrun, Michael ; et al.	2003-06-05
Antagonists of neuropilin receptor function and use thereof App 20020132774 - Klagsbrun, Michael ; et al.	2002-09-19
Heparin binding mitogen with homology to epidermal growth factor (EGF) Grant 5,811,393 - Klagsbrun , et al. September 22, 1	1998-09-22
System for assaying binding to a heparin-binding growth factor receptor Grant 5,789,182 - Yayon , et al. August 4, 1	1998-08-04
Cells expressing a substantial number of surface high affinity HBGF receptors but relatively few low affinity HBGF binding sites and system for assaying binding to HBGF receptor Grant 5,270,197 - Yayon , et al. December 14, 1	1993-12-14
Method of purifying endothelial cell growth factors using immobilized heparin Grant 4,882,275 - Klagsbrun November 21, 1	1989-11-21
Stimulating cell growth Grant 4,440,860 - Klagsbrun April 3, 1	1984-04-03

Company Registrations

NCAGE Code	4B5F1	KLAGSBRUN MICHAEL
CAGE Code	4B5F1	KLAGSBRUN, MICHAEL

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.